-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OOyo5Lu7fT8jK9bDdD1O93np6c6xKvvHXDGXLqofYSK2c87piR7La7doFqIGSPF4 CcQLnzAl/myrdtPXOcwFQg== 0001203944-09-000072.txt : 20090916 0001203944-09-000072.hdr.sgml : 20090916 20090916152058 ACCESSION NUMBER: 0001203944-09-000072 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090916 DATE AS OF CHANGE: 20090916 EFFECTIVENESS DATE: 20090916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RAPTOR PHARMACEUTICALS CORP. CENTRAL INDEX KEY: 0001203944 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980379351 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-120712 FILM NUMBER: 091072015 BUSINESS ADDRESS: STREET 1: 9 COMMERCIAL BLVD, SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-382-1390 MAIL ADDRESS: STREET 1: 9 COMMERCIAL BLVD, SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND CLAN CREATIONS CORP. DATE OF NAME CHANGE: 20060531 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND CLAN CREATIONS CORP DATE OF NAME CHANGE: 20021106 D 1 primary_doc.xml X0502 D LIVE 0001203944 RAPTOR PHARMACEUTICALS CORP. 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390 HIGHLAND CLAN CREATIONS CORP. HIGHLAND CLAN CREATIONS CORP DELAWARE Corporation true 2005 Christopher M. Starr 9 Commercial Blvd., Suite 200 Novato CA 94949-6118 Executive Officer Director Raymond W. Anderson 9 Commercial Blvd., Suite 200 Novato CA 94949-6118 Director Erich Sager 9 Commerical Blvd., Suite 200 Novato CA 94949-6118 Director Kim R. Tsuchimoto 9 Commercial Blvd., Suite 200 Novato CA 94949-6118 Executive Officer Todd C. Zankel 9 Commercial Blvd., Suite 200 Novato CA 94949-6118 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2009-08-21 false true true false 50000 2386000 2386000 0 Includes US and non-US sales. false 4 0 59360 Compensation provided to non-US placement agent on the basis of solicitation of non-US investors. 0 false RAPTOR PHARMACEUTICALS CORP. Kim R. Tsuchimoto Chief Financial Officer Kim R. Tsuchimoto 2009-09-10 -----END PRIVACY-ENHANCED MESSAGE-----